Dry Eye Disease

MONTEREY, Calif. — Women treated with Tyrvaya had consistent outcomes regardless of their menopause status, according to a study presented at the Women in Ophthalmology Summer Symposium.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses how cases of Demodex blepharitis can sometimes masquerade as severe dry eye disease.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lola Idowu, MD, discusses various skills labs from the meeting and global updates in ophthalmology.

Sight Sciences has completed enrollment in the SAHARA trial, which is evaluating the TearCare system to treat the signs and symptoms of dry eye disease, according to a press release.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses meibomian gland dysfunction in patients 1 month after TearCare treatment.

This is a dry eye disease blog. From time immemorial, we have struggled with the out-of-pocket costs of the drugs we prescribe. All of those drugs enjoyed patent protection, allowing the manufacturers to control prices.

The FDA accepted a new drug application for NOV03, an investigational treatment for the signs and symptoms of dry eye disease, according to a press release from Bausch + Lomb and Novaliq.

MONTEREY, Calif. — OC-01 nasal spray showed a significant decrease in the signs and symptoms of dry eye in patients with autoimmune disease and associated dry eye disease.

AR-15512, a transient receptor potential melastatin 8 agonist, demonstrated significant improvement of dry eye disease signs, symptoms and related quality of life in a phase 2b study.

Alcon has entered into a definitive merger agreement to acquire Aerie Pharmaceuticals in a deal worth approximately $770 million, according to a press release.